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Anesthesia and climate change 
Why anesthetists should care
The environmental 
footprint of  
anesthetic agents
Greenhouse gases are the main drivers of climate change.  
Anesthesia practice and contemporary technologies can  
help anesthetists reduce anesthetic waste to minimize 
the negative impact on our environment.
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First, do no harm
Reducing our environmental impact can protect 
both patients and planet, and save money
Human activity is drastically changing our atmosphere1,  and anesthetic agents 
contribute to climate change.4 By implementing relatively simple changes in 
choice of anesthetic agent or ventilator settings, every individual anesthetist 
can make a difference for our planet.
1. 
... probability that greenhouse  
gases have caused increases in  
the Earth’s temperature.1 
>95%
Experts agree:  human activity is changing  
our planet1
The Earth is becoming warmer overall. The 10 hottest 
years ever recorded have occurred since 1998, with seven 
of the 10 occurring between 2010–2017.2 This temperature 
increase is resulting in a dramatic change in ecosystems, 
leading to unpredictable weather patterns, devastating 
storms, biodiversity loss, long-term droughts, wildfires, 
and desertification.
The Intergovernmental Panel on Climate Change, operat-
ing under the authority of the United Nations, identified 
human-caused emissions as the primary source of 
increases in atmospheric greenhouse gases. These levels 
have increased by more than 40% in the last 150 years.1 
How do anesthetic agents contribute to 
climate change? 
Modern anesthetic agents are potent greenhouse gases. 
In typical use, less than 5% of the total delivered halogen-
ated anesthetic is metabolized by the patient; the remain-
der is routinely vented into the atmosphere through the 
operating room scavenging system.3 
Two main attributes determine the global warming  
potential (GWP) of a volatile agent: the atmospheric half-
life, and the potency of the agent to capture infrared light 
in addition to the natural greenhouse gases. There is a  
significant divergence in each agent’s global warming 
effects due to differences in heat-trapping capacity  
and atmospheric half-life. 
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The global warming potential of
a halogenated anesthetic is up to 
3,700 times greater than CO₂.4 
Molecule GWP (100y)
CO₂ 1
CH₄ 28
N₂O 296
Isoflurane 350
Sevoflurane 575
Desflurane 1526
SF₆ (sulfur hexafluoride) 23,500
Compound Lifetime (y)
Sevoflurane 1.2
Isoflurane 3.6
Desflurane 10
Nitrous oxide 114
Table 3: Tropospheric lifetime  
of inhaled anesthetics4
Table 1: Atmospheric record of halogenated anesthetics.
Red line: Northern hemisphere. Blue line: Antarctica 5
Table 2: Global Warming Potential (GWP)3
Halothane and isoflurane are halogenated chlorofluoro-
carbons (CFC) while sevoflurane and desflurane are hydro-
fluorocarbons (HFC), all known as high-GWP gases. These 
gases have GWP numbers in the hundreds or thousands.4 
This means that for their mass, they trap hundreds to 
thousands of times more heat than CO₂, which is the 
baseline by which all other emissions are measured.6
By definition, the GWP of CO₂ is 1. In comparison, 1 kg  
of nitrous oxide (N₂O) has a GWP of 296, the same heat 
trapping effect as 296 kg of CO₂ (Table 2).
The atmospheric concentrations of anesthetic gases  
– particularly desflurane – are rapidly increasing (Table 1).7
There are dramatic differences in the length of time that 
these gases remain in the atmosphere. While sevoflurane 
clears from the atmosphere relatively quickly, N₂O emitted 
today remains in the atmosphere for more than 100 years, 
on average (Table 3).6 
Anesthetic gases are typically excluded from environmen-
tal agreements because of their medical necessity. None-
theless, the effects of anesthetic agents are significant. 
The anesthesia practice in an average midsize hospital 
has an environmental effect comparable to that of up  
to 1,200 cars per year.8
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Other factors that determine the climate  
effects of anesthetic agents
Ventilator settings also dictate the amount of volatile  
anesthetic waste. The combined effect of agent choice 
and ventilator setting results in a strikingly divergent 
environmental impact for an equal depth of anesthesia. 
The heat-trapping effects of eight hours of volatile anes-
thetic use is comparable to driving an average car between 
100–13,000 km (60–8,000 miles), depending on the choice 
of volatile agent and ventilator setting.
Using another comparator: In a timeframe of only 5 days  
of anesthesia of 8 hours per day with 1 MAC sevoflurane at 
2 L FGF, an anesthetist emits an equivalent of 280 kg CO₂. 
The same period with 1 MAC desflurane at 6 L FGF emits 
16,000 kg of CO₂ equivalent. As such, an anesthetist can 
unknowingly emit in one week as much CO₂ equivalents 
through volatiles alone as an average US citizen emits  
in a whole year. 4
Some anesthetic gases also damage  
the ozone layer
In addition to greenhouse effects, some volatile anesthe-
tics also have the capability to deplete the ozone layer.
CFCs, such as halothane or isoflurane, eventually reach 
the upper stratosphere into the ozone layer. When a CFC  
is hit by an ultraviolet (UV) photon from sunlight, a free 
chlorine radical is released. The chlorine acts as a catalyst 
to turn ozone (O3) into oxygen (O₂), after which the chlo-
rine radical is regenerated. This cycle can be repeated 
millions of times, and as such, a single CFC molecule can 
destroy millions of ozone molecules before the chlorine 
radical is finally neutralized. 80% of all stratospheric ozone 
depletion is attributed to released CFCs. Sevoflurane and 
desflurane lack chlorine atoms, and have therefore no  
effects on the ozone layer. 17
*8h/day at a Fresh Gas Flow (FGF) of 2 L. 4,8
2 weeks of  
desflurane use* 
equals driving  
a car around  
the globe!
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Anesthetic FGF (L/min) Grams/hour GWP₂₀ CDE₂₀ (g/h) Ratio₂₀ CDE
2% sevoflurane 2 20.0 349 6980 1
1.2% isoflurane 0.5 2.8 1401 3881 0.6
1 5.5 1401 7762 1.1
2 11.1 1401 15,551 2.2
6 % desflurane 0.5 12.6 3714 46,796 6.7
1 25.2 3714 93,593 13.4
2 50.4 3714 187,186 26.8
Table 4 shows that one hour  
of sevoflurane at 2% with a fresh 
gas flow of 2 L/min emits a heat 
trapping effect equal to almost  
7 kg of CO₂. In contrast, one hour 
of desflurane at 6% with the same 
FGF of 2 L, emits a heat trapping 
effect equal to almost 187 kg  
of CO₂.8
The impact of greenhouse gas emissions from anesthetic 
agents can easily be reduced significantly by adhering to a 
few basic principles. These changes can be made without 
risking patient safety.
Change the anesthetic agent
Not all anesthetic agents have the same GWP nor are  
they used equally. Because both the MAC and the intrinsic 
GWP dictate the ultimate effect, desflurane has a 26-fold 
effect as sevoflurane for an equal level of anesthesia with 
an equal FGF. As such, one hour of anesthesia at equal 
ventilator settings and depth of anesthesia with desflu-
rane emits the same amount of heat trapping effect as  
26 hours of anesthesia with sevoflurane.4 
Replacing desflurane with sevoflurane is therefore an 
obvious first step that can dramatically reduce any 
anesthetist’s greenhouse gas emissions.
Reducing fresh gas flow to reduce 
consumption
Minimizing the fresh gas flow will decrease the consump-
tion of volatile anesthetics and their emission in the  
atmosphere. In low-flow anesthesia – conventionally  
defined as a fresh gas flow of less than 1.0 L/min – a re-
breathing system uses less anesthetic agent than open 
systems. Such settings emit less gas into the atmosphere, 
and improve the flow dynamics of the inhaled air.
Reducing the fresh gas flow (FGF) during general anesth- 
esia is a simple strategy that leads to cost savings from 
reduced consumption of volatile anesthetics.9 Lower 
fresh gas flows can be achieved by manual adjustments 
of the gas settings, or by using an automated gas  
control function. 
It’s clear that the impact of anesthetic agents is significant. Lacking a 
standardized global approach, improving awareness of the impact any  
individual anesthetist can make, is an essential first step to dramatically 
reducing the emissions from the anesthesia sector. 
How can we reduce the impact of  
anesthetic gases on climate change?
Table 4: Global warming impact of one hour of volatile agent use
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Low-flow anesthesia with automated gas control
An automated gas control function automatically  
adjusts FGF and agent concentration to reach set end- 
tidal targets for anesthetic agent (EtAA) and inspired O₂. 
This permits a combination of extremely stable levels of 
end-tidal volatile concentration with minimal consump-
tion. The system automatically ensures the desired target 
values for inspired oxygen and EtAA, while efficiently 
limiting wastage. It provides simultaneously a large reduc-
tion in the consumption of anesthetic agent and a 
completely controlled and stable administration of vola-
tile anesthetics, permitting both maximal patient safety 
and volatile agent conservation.10  In addition, even in high 
fresh gas flow setting, some of these modern ventilators 
will automatically restrict the fresh gas flow to the minute 
volume, and as such limit wastage even in the open  
flow setting.
Advantages of automated gas control
Automated gas control reconciles safe and efficient  
induction and maintenance of anesthesia with minimized 
agent wastage.
Automated gas control guarantees a secure combination 
of stable volatile administration levels with minimal flow 
without the need for constant adjustments of the ventila-
tor settings, improving workflows. A study comparing 
manual-controlled low-flow anesthesia to automatic- 
controlled delivery showed that 244 adjustments were  
required in manual mode to reach and keep adequate  
anesthesia levels compared to zero when using auto- 
mated gas control.11 
Automated control of gases also reduces the risk of  
hypoxic mixtures or inappropriate depth of anesthesia 
and ultimately promotes patient safety.10
A higher fraction of rebreathing will also:
• improve the flow dynamics of inhaled gases.
• increase mucociliary clearance.
• maintain body temperature and reduce water loss.
Significant cost savings with lower flows
The cost of anesthetic agent accounts for a large portion 
of the total cost of ownership (TCO) for anesthesia 
machines. Implementation of a low-flow strategy easily 
permits a reduction in consumption of volatile anesthetics 
by 25–50% compared to conventional fresh gas flow 
(2L–4L/min), while providing a more stable level of FiAA 
and FiO₂ if using automated gas control.8 With an average 
of 10 anesthesia devices running 2000 hours/year, this 
would account to a reduction of 170,000 to 680,000 ml/
year.8,13 At an estimated price of 0.50 $/ml, this represents 
a saving of $85,000 to $340,000/year.*
Hospitals have reported significant agent reductions  
by changing  to a low-flow strategy using automated gas 
control (AGC), many between 30 –42 %.12 This results in  
significant cost savings, as well as dramatic reductions  
in environmental impacts.
One doesn’t really appreciate how  
thin the atmosphere is, to what extent  
we are capable of destroying the planet  
– to what extent we need to protect it. 
Thomas Pesquet, Astronaut, European Space Agency (ESA)
Cost saving/year*
$ 340,000
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Simple actions to limit your  
hospital’s ecological  
impact from anesthetics
1. Minimize desflurane usage 
Keeping all parameters equal, but changing the 
agent from desflurane to sevoflurane can reduce 
your environmental impact by as much as 96%.14
2. Use low-flow anesthesia when possible  
Lower fresh gas flows (FGF), preferably with an  
automated gas control, greatly reduce agent  
consumption, delivering positive outcomes for  
patients, hospital spending, and the environment. 
3. Avoid spills  
It may sound obvious, but avoiding spills  
of liquid volatiles can reduce a facility’s  
environmental footprint. 
4. Avoid using nitrous oxide  
Nitrous oxide is used in higher concentrations than 
other anesthetic agents and has an extremely long 
atmospheric half-life. Limiting use of N₂O can dra-
matically reduce greenhouse gas emissions.15,16
In summary, there are easy ways to reduce your facility’s  
environmental footprint without compromising patient safety.  
By choosing environmentally responsible agents and delivery modes, 
each anesthetist can reduce their environmental impact at a level 
equivalent to the total emissions of 1 to 50 average US citizens.
Adherence to these few basic principles can result in a 99% reduction in greenhouse 
gas emissions while preserving the convenience and advantages of volatile anesthesia.
Getinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization  
departments and for life science companies and institutions. Based on our firsthand experience and close  
partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the  
everyday life for people – today and tomorrow.  
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